pubmed:abstractText |
The biological behavior of neuroblastomas detected through mass screening (MS, </=1 year of age) and that of mass screening-negative later-presenting (MSN, >1 year of age) neuroblastomas have been reported to differ in many studies. To investigate the biological differences between these two groups, we analyzed the differences in mRNA profiles.
|
pubmed:affiliation |
Department of Pharmacology, Department of Pediatrics, Department of Pediatric Surgery, Nihon University School of Medicine, 30-1 Oyaguchikami-cho, Itabashi-ku, Tokyo, 173-0032, Japan. tnagata@med.nihon-u.ac.jp
|